Chambers Research is conducted by 200 Research Analysts, across 200 jurisdictions and provides nearly 6,000 rankings tables. Annually we collect hundreds of thousands of responses from clients, the majority via in-depth interview. Learn more about our methodology.
Superb private equity practice attracting high-calibre mandates from leading US and Chinese funds, advising on investments and exits across the region. Maintains a strong China-based private equity practice and also handles private equity mandates in South Asia, as well as from its Japan and South Korea offices. Also active in M&A, advising major Asian corporates on transactions throughout the region and dominating the North Asian market with skilled lawyers housed in Greater China and Japan. The firm offers over two decades of experience advising on high-value M&A work, including headline transactions for clients in the TMT, life sciences and automotive sectors.
"We have a lot of respect for them," reveals a peer, while a client praises the team for its "incredible attention to detail."
The practice is held in high esteem by a market source for its "good private equity pedigree."
"They are a pleasure to work with and their performance was strong, as expected," reports a client, explaining that the lawyers "communicate well, understand clients' needs well and have commercial awareness."
Advised New Frontier Corporation on its USD1.3 billion acquisition of United Family Healthcare from TPG, Fosun and other shareholders.
Represented KKR in relation to its investment with IGIS Asset Management and the National Pension Service of Korea to acquire a real estate project.
Acted for KKR on its acquisition of certain international operations, valued at approximately USD2.2 billion, from Campbell Soup Company.
The head of the Asia practice and main contact in Japan is David Sneider. Hong Kong-based Ian Ho is the main contact for the China practice.